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Human tumour clonogenicity in agar is improved by cell-free
ascites
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Summary Replacement of enriched CMRL 1066 medium by cell-free ascites from tumour patients in the
human tumour clonogenic assay described by Hamburger and Salmon (1977) increased plating efficiency for
ovarian cancer cells by a median of 8-fold (range 0.4-1012 fold). In 40 experiments, two cases had a lower
plating efficiency when cultured in cell-free ascites, 10 grew neither in standard medium nor in cell-free ascites
and in two cases, growth was only observed in cell-free ascites. With standard medium, we observed 53%
growth (>5 colonies/dish) and 41% evaluable for chemosensitivity testing (>30 colonies/dish). With cell-free
ascites as culture medium, these figures were 71% and 63%, respectively. While under standard conditions the
highest plating efficiency obtained was 0.25%, in 21% of the experiments done with cell-free ascites a plating
efficiency higher than 1% was reached. We conclude that cell-free ascites is able to stimulate proliferation of
ovarian cancer cells in agar and that the use of it extends the applicability of the clonogenic assay.
The human tumour clonogenic assay, developed by
Hamburger and Salmon (1977), appears potentially
useful for predicting clinical response of patients to
anticancer drug therapy (Salmon et al., 1978; Von
Hoff et al., 1981a) and screening of new anticancer
drugs (Salmon et al., 1981; Von Hoff et al., 1981b).
However, the low plating efficiency (PE) obtained
with this standard technique usually ranging from
0.001 to 0.1%-often precludes drug sensitivity
evaluation. For such tests, at least 30 colonies per
control dish are considered necessary. Furthermore,
the high number of cells which need to be plated
per dish limits the number of drugs that can be
tested for a given specimen. Thirdly, the slow
growth of the colonies compels a long culturing
time before scoring.
There is a clear need for a compound that
stimulates the proliferation of the clonogenic cells
in agar. The original description of the assay
(Hamburger and Salmon, 1977) included mineral oil
primed mouse spleen cell conditioned medium, but
this has generally been omitted from the standard
composition of the medium (Alberts et al., 1981;
Buick and Fry, 1980; Daniels et al., 1981;
Hamburger et al., 1981; Von Hoff et al., 1981a)
since for most tumour types it had no influence on
the P.E. Other additions to the medium, like
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epidermal growth factor or a fibroblast feeder layer,
have been tested for their colony stimulating
activity (Hamburger et al., 1981) with moderate
success.
Since it has been reported that cell-free ascites
(CFA) may stimulate proliferation of neoplastic
cells (Vaage and Agarwal, 1979), we tested the
human tumour colony stimulating activity of CFA
from patients with malignant ascites and found a
marked increase in PE of human ovarian tumour
cells. Part of these data have been published as an
abstract (Uitendaal et al., 1982).
Materials and methods
Samples of solid tissue and malignant peritoneal
effusions were obtained from patients with ovarian
cancer, both untreated and chemotherapeutically
treated, but always minimally one week and usually
more than a month after the last treatment.
Handling of the tumour specimens and the culture
procedure was essentially as described by others
(Hamburger and Salmon, 1977) and performed
under sterile conditions at ambient temperature.
Solid tumours were minced with curved scissors,
passed through a 40 mesh stainless steel screen and
through 18, 21 and 23 gauge needles and then
washed twice with Hank's Balanced Salt Solution
(HBSS)+ 10% heat-inactivated fetal calf serum.
Ascites fluids containing 104 U 11 heparin were
centrifuged for 30min at 200g in 0.51 sterilised glass
bottles. The supernatants were processed as
described below. The pellets were treated with a
NH4Cl-lysing buffer to remove red blood cells and
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washed twice with HBSS + 10% heat-inactivated
foetal calf serum. Viability as determined with trypan
blue ranged for solid tumours from 1-95% and for
ascites cells from 30-100%. The supernatant of each
batch of ascites was recentrifuged for 10min at
450g in 50ml tubes to remove possible cells and
frozen at -20° till further use. When protein had
been precipitated during freezing and thawing, it
was removed by centrifugation for 10min at 450g.
For a limited number of experiments, CFA was
heat-inactivated by heating for 30min at 56°C.
With the standard method applying 35mm Petri
dishes, cells were plated in a top layer consisting of
0.3% agar in enriched CMRL 1066 medium with
various additions (Hamburger and Salmon, 1977)
onto the bottom layer of 0.5% agar in McCoy's 5A
medium with additions (Hamburger and Salmon,
1977). No conditioned medium was used. All media
used were obtained from Gibco (Paisley, Scotland),
2-mercapto-ethanol and insulin were from Sigma
(St. Louis, Missouri) and all other chemicals were
Analar grade. In the stimulation experiments, the
enriched CMRL 1066 medium from the top layer
was replaced by mixtures of 25%, 50% and 75%
CFA with enriched CMRL 1066 or 100% CFA. In
general, 5 x 105 viable cells were plated per dish, but
with viabilities below 25%, 2x 106 total nucleated
cells were added. Plating was done in triplicate. At
Day 1, the dishes were checked and discarded if cell
clumps would make them non-evaluable for colony
growth scoring. The dishes were kept for 3 weeks in
a humidified incubator at 37°C with 5% C02-95%
air, after which colonies were counted using a Leitz
inverted microscope at 40 x or 100 x magnification.
Only spherical aggregates with a dense core and a
minimal diameter of 50,um were scored as colonies.
Although the density of these colonies prevented
accurate counting of the number of cells it consisted
of, we estimate that they contained at least 40 cells.
PE was expressed as
no. of colonies
x 100.
no. of viable, nucleated cells plated
Percentages in the Results Section and the tables
are based on the number of non-infected
experiments.
Results
Colony stimulation experiments were performed
with CFA from ovarian cancer patients, but
autologous CFA was not always used.
Response to increasing amounts ofCFA
The number of colonies usually increased with
increasing amounts of CFA in the top layer,
although the relationship was not linear, as
indicated in Table I for several representative
specimens cultured in different batches of CFA.
Sometimes, however, culturing in 50% or 75% CFA
in enriched CMRL led to a higher number of
colonies per dish than 100% CFA as top layer
medium. This phenomenon was not specific for
certain batches of CFA or tumour cells, but was
dependent on the combination of CFA batch and
tumour cells.
CFA which stimulated at 50% or 75%, always
stimulated at 100% too, although sometimes not
maximally.
Table I Stimulation of clonogenic tumour cells as a
function of the amount ofCFA added
Amount ofCFA added to the
top layer
Tumour Ascites
no. batch no. 0% 25% 50% 75% 100%
Effusions
1 it 0.3* 17.5 31.1 86.3 100 (1712)
2 2t 0.3 2.1 4.5 5.9 100 (5243)
4 0.2 3.0 5.3 11.1 100 (8715)
4 HIT 0.1 0.7 4.5 20.1 100(16191)
Solid
3 4 4.2 38.7 72.9 65.4 100 (2916)
4HI$ 6.4 56.9 93.3 87.7 100 (2114)
*Number ofcolonies per dish given as percentage of the
number of colonies in dishes with the highest stimulation.
Absolute number of colonies in those dishes is given in
parentheses in the last column.
tAutologous CFA.
$HI=heat inactivated; 30min at 56°C.
Increase in PE using pure CFA
With 16 specimens from 10 patients, the PE was
evaluated using 17 CFA batches for a total of 40
stimulation experiments, 2 of which were not
evaluable because of infection. Response to CFA
was heterogeneous depending on the CFA batch
and on the individual tumour. Figure 1 gives some
examples of stimulation of colony formation
obtained with different CFA batches. Colony
formation of tumour A was decreased by one CFA
batch, while with other batches, an increase of more
than 2-fold was obtained (note the logarithmic scale
on the ordinate). Tumour I did not form colonies in
enriched CMRL 1066 medium (PE<0.001) but was
stimulated by some CFA batches to form a
measurable number of colonies. With the 38 non-
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Figure 1 PEs obtained with cells from 9 different ovarian tumours using either enriched CMRL 1066
(standard) medium (black bars) or various batches of CFA (white bars) as top layer medium. The shaded
bars indicate PEs obtained with autologous CFA.
ranged from 0.4 to 1012-fold (median: 8-fold). In
2/38 experiments, CFA decreased the PE. Two
specimens formed colonies only when CFA was
added, while in 10 cases neither standard conditions
nor those including CFA yielded colonies. CFA of
patients on chemotherapy also stimulated colony
growth and there was no association between
treatment and presence of stimulatory factors.
Nineteen specimens from 11 patients were
cultured with the standard enriched CMRL 1066
medium. Two samples appeared to be
contaminated. In Table II, the distribution of PEs
Table II Distribution of ovarian tumour cultures over
PE intervals using standard medium or CFA
PE intervals
Top
medium <0.001 0.001-0.01 0.01-0.1 0.1-1 >1
CMRL 1066 47% 12% 23% 18% 0%
CFA 29% 16% 21% 13% 21%
of the remaining experiments are given and
compared with the distribution of PEs obtained
with the 38 stimulation experiments mentioned
above. The percentage of experiments with PE
below 0.1% was reduced by CFA, while in 21% PE
increased to above 1% by adding CFA.
Special CFA batches
As is shown in Figure 1, autologous CFA does not
necessarily provide optimal stimulation for effusion-
derived tumour cells. The two examples in Table I
using CFA batch 4 and 4HI show that heat-
inactivated CFA led to equal or higher stimulation
as compared to the untreated batch, suggesting that
the compounds responsible for the stimulation are
stable at 56°C.
Consequencesfor chemosensitivity test
Generally, tumours forming >5 colonies per dish
are considered to be growing, while a minimum of
30 colonies per control dish is accepted for reliable
chemosensitivity testing (see e.g. Salmon et al., 1981;
Von Hoff et al., 198lb). Table III gives the
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Table III Success rate with human ovarian tumours in
the clonogenic assay using standard medium or CFA
Growth Evaluable
Top medium >5 colonies/dish >30 colonies/dish
CMRL 1066 53% 41%
CFA 71% 63%
percentages of cultures in which these limits were
reached with either enriched CMRL 1066 medium
(n= 17) or undiluted CFA (n=38) as top layer
medium. Success rates for stimulation experiments
were higher than for the standard method.
Discussion
Recently, data have been published suggesting that
ascites can stimulate proliferation of neoplastic cells
(Vaage and Agarwal, 1979). It has been tested
unsuccessfully as a colony stimulating factor in a
1:4 dilution (Hamburger et al., 1978). However,
since whole ascites is the natural environment in
which many neoplastic cells proliferate and since it
can be obtained easily and without cost, the effect
of CFA both diluted and undiluted were studied.
Although stimulation was observed already with a
limited amount of CFA, often colony stimulation
was only apparent with undiluted CFA in the top
layer, suggesting that the positive effect could have
been missed with addition of diluted ascites.
PEs obtained with CFA (Table II) were
comparable with those achieved with a different
agar system (Tveit et al., 1981) requiring special
equipment for oxygen concentration control, and
replacement of the liquid top layer at set time
intervals (Courtenay and Mills, 1978).
As is shown in Table III, the use of CFA instead
of enriched CMRL increased the percentage of
samples evaluable for chemosensitivity testing.
Moreover, since the colonies found in CFA were
usually larger than the corresponding ones grown in
standard medium (data not shown), dishes with
CFA may be ready for scoring of colonies sooner
than dishes with standard medium.
Preliminary studies have shown that has no
influence on chemosensitivity of the tumour cells
(data not shown) and this suggests that colonies in
CFA and in enhanced CMRL are representative for
the same cell populations. Studies with a larger
number of specimens have to substantiate this.
The heterogeneity of response to CFA (Table I;
Figure 1) and the fact that maximum stimulation
was at times seen with 50% or 75% CFA instead of
100% suggest that CFA contains a mixture of
stimulatory and inhibitory factors. If the inhibitory
factors could be removed from the preparation, PE
would probably increase even more and the
requirement for less cells per dish would allow
testing of more drugs for chemosensitivity per
tumour specimen. The findings warrant further
investigation to study whether ascites also
stimulates tumour cell proliferation in the
peritoneal cavity. Such a finding would have
considerable clinical impact.
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